Comparison of Two Analgesic Strategies After Scheduled Caesarean

NCT ID: NCT04755712

Last Updated: 2024-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-22

Study Completion Date

2022-10-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the superiority of square lumbar block to ropivacaine compared to intrathecal morphine in the efficacy of postoperative analgesia following scheduled caesarean.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interventional, comparative, randomized, controlled study versus reference therapeutic strategy, in 2 parallel groups, double-blind (patient and evaluator), single-center, aiming to demonstrate the superiority of ropivacaine in square lumbar block versus intrathecal morphine, on the efficacy of post-operative analgesia, following a scheduled caesarean.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ropivacaine in quadratum lumburum block 2

Ropivacaine will be administrated in perineural in quadratum lumburum block 2 after the caesarian.

Group Type EXPERIMENTAL

Rachianesthesia

Intervention Type DRUG

Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)

Morphine

Intervention Type DRUG

Morphine via pump (patient controlled analgesia)

Intrathecal morphine

Morphine will be administrated in intrathecal

Group Type ACTIVE_COMPARATOR

Rachianesthesia

Intervention Type DRUG

Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)

Sodium Chloride Injection

Intervention Type DRUG

Subcutaneous injection of Sodium chloride at the usual quadratum lumburum block 2 (QLB2) injection site under ultrasound ("sham-QLB2").

Morphine

Intervention Type DRUG

Morphine via pump (patient controlled analgesia)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rachianesthesia

Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)

Intervention Type DRUG

Sodium Chloride Injection

Subcutaneous injection of Sodium chloride at the usual quadratum lumburum block 2 (QLB2) injection site under ultrasound ("sham-QLB2").

Intervention Type DRUG

Morphine

Morphine via pump (patient controlled analgesia)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bupivacaine and sufentanil sham-QLB2 injection of morphine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient to undergo a scheduled caesarean under spinal anesthesia, for the birth of a term baby with a Pfannenstiel-type incision;
* Patient in good health ;
* Patient able to understand the information related to the study, read the information leaflet and agree to sign the consent form.

Exclusion Criteria

* Pregnancy less than 37 weeks with amenorrhea;
* Multiple pregnancy;
* Fetal pathology known at the time of inclusion;
* Body mass index\> 45 kg / m²;
* History of scoliosis or spine surgery;
* History of chronic pain associated with taking opiates, neuropathic pain, neurological pathology;
* Preoperative anemia (blood hemoglobin \<9 g / dL);
* Hypersensitivity to ropivacaine or other local anesthetics with amide bond;
* Hypersensitivity to morphine or opioids;
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MAUPAIN

Quincy-sous-Sénart, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Giral T, Delvaux BV, Huynh D, Morel B, Zanoun N, Ehooman F, Garnier T, Maupain O. Posterior quadratus lumborum block versus intrathecal morphine analgesia after scheduled cesarean section: a prospective, randomized, controlled study. Reg Anesth Pain Med. 2024 Sep 4:rapm-2024-105454. doi: 10.1136/rapm-2024-105454. Online ahead of print.

Reference Type DERIVED
PMID: 39237149 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A03334-35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.